Flerie AB (publ)
STO: FLERIE.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Ted Fjallman
- Employees
- 8
- Headquarters
- Stockholm, Sweden
- IPO year
- 2024
- Market cap
- SEK 2.3B
- Website
- https://www.flerie.com
Loading FLERIE…
Loading profile data…Frequently asked questions about FLERIE
What does Flerie AB (publ) (FLERIE.ST) do?
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel. Flerie AB (publ) was founded in 2011 a...
Where does FLERIE.ST trade?
Flerie AB (publ) (FLERIE.ST) trades on the Stockholm Stock Exchange.
What sector is FLERIE.ST in?
Flerie AB (publ) (FLERIE.ST) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Flerie AB (publ)?
Ted Fjallman is the chief executive officer of Flerie AB (publ) (FLERIE.ST).
Where is Flerie AB (publ) headquartered?
Flerie AB (publ) is headquartered in Sweden.
Does FLERIE.ST pay a dividend?
Flerie AB (publ) (FLERIE.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FLERIE.ST go public?
Flerie AB (publ) (FLERIE.ST) completed its initial public offering in 2024.